[1]
Oki Nugraha Putra et al. 2023. Six Months of Bedaquiline-Pretomanid-Linezolid (BPaL) Regimen in Patients with Drug-Resistant Tuberculosis: A Narrative Review. Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI). 5, 2 (Jul. 2023), 83–95. DOI:https://doi.org/10.32734/jetromi.v5i2.12373.